Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIn the UK private market, Mounjaro 15mg typically costs somewhere between £270 and £375 per four-week pen, depending on the provider — though prices vary and not every quoted figure includes a prescription, clinical review or delivery. Mounjaro is a prescription-only medicine, so any legitimate route to it involves a clinical assessment by a prescriber, not just a transaction. If you've landed here after seeing a range of prices and feeling genuinely confused about what you're comparing, that's an entirely reasonable response to a market that isn't always transparent about what a headline number actually buys you.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The biggest misconception in any Mounjaro 15mg price comparison is the assumption that the number on the page represents the full cost. It often doesn't. Consultation fees, prescription charges, delivery, and dose-review support are routinely presented as optional extras (or quietly absent) on certain platforms. A price that looks £60 lower than a competitor may become comparable, or higher, once those items are added back in.
Eli Lilly revised Mounjaro's UK list price from 1 September 2025, and the highest-dose pen's list price rose from around £122 to around £330. Private providers set their own prices on top of that. The full picture of how Mounjaro pricing works across the dose range explains why the 15mg pen sits at the upper end of the market. What matters here is that reported private prices since the increase have ranged roughly £149 to £375 per month across all doses, with 15mg predictably at the higher end. Hedged as widely reported figures, not guarantees.
A genuine comparison accounts for what arrives with the medicine: clinical oversight, a verifiable supply chain, aftercare if something goes wrong. A pen posted from an unverified seller is not the same product as a pen dispensed by a GPhC-registered pharmacy following a clinical assessment, even if the pen looks identical.
Strip out the extras and you're not comparing treatment — you're comparing pen costs. The things most commonly absent from a low headline price are: a consultation fee (some providers charge £20–£50 or more separately), a prescription charge, delivery (particularly tracked, temperature-appropriate courier services), and any form of clinical re-review before a repeat order is dispatched.
For 15mg specifically, the clinical stakes of those extras are higher than at the starter doses. Reaching 15mg means a patient has already titrated through 2.5mg, 5mg, 7.5mg, 10mg and 12.5mg. Each step up requires a prescriber to confirm tolerability and continued suitability. If that review is absent, a dose increase isn't supervised, it's just posted. How Mounjaro works as a treatment, and why titration matters clinically, is worth understanding before comparing prices at the top of the schedule.
Delivery is another variable. Temperature-sensitive medicines need appropriate cold-chain handling. A tracked, pharmacy-dispatched courier service is a different proposition from standard post. That operational difference has a cost, and a provider absorbing it into the quoted price is doing something the cheapest listings often aren't.
A single, transparent price at nume covers the consultation, the prescription, the medicine and free next-working-day DPD delivery. There are no subscription commitments and no auto-renewals; every repeat goes back to a prescriber for review before it ships. We don't run discount codes, vouchers or promotional pricing. We are, on purpose, not competing on being the cheapest.
What that buys you is a regulated, clinician-reviewed route through a GPhC-registered pharmacy, verifiable directly on the GPhC register, premises number 9012878. Our prescribers, overseen by our clinical team, personally review every consultation the same day. Current treatment pricing, including the 15mg tier, is shown on our weight-loss treatments page.
Worth knowing: for context on how lower doses are priced by comparison, our Mounjaro 5mg price comparison page covers the mid-schedule picture, and our broader Mounjaro price comparison sets out the full dose-by-dose context.
Mounjaro 15mg is the maximum licensed dose. The MHRA licenses it as a prescription-only medicine, which means a prescriber (not a checkout) determines whether you should be on it. NICE's appraisal of tirzepatide, TA1026, sets out the clinical framework for who tirzepatide is recommended for in the NHS; private eligibility criteria are set by the medicine's SmPC, reviewed prescriber by prescriber.
The MHRA has also warned repeatedly about counterfeit weight-loss pens circulating online. A low price from an unverifiable seller is a red flag, not a bargain. Suspect sellers can be reported at the MHRA's Yellow Card service. The right question isn't which 15mg listing is cheapest, it's which provider can demonstrate genuine supply, regulated dispensing and clinical oversight. A small saving answers none of that.
If you're on a lower dose and looking ahead, the dose-by-dose pricing changes page explains when and why costs shift as treatment progresses. For those still at the earlier stages, the 2.5mg price comparison covers where most patients begin.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.